Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
IN8BIO, INC. (INAB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update • Presented positive INB-200 Phase 1 data in an oral presentation at the American Society of Clinical Oncology Annual Meeting showing 100% of treated patients have exceeded historical median progression-free survival • INB-400 on track to initiate enrollment in glioblastoma multiforme in the second half of 2023. The Phase 2 trial will initially enroll newly diagnosed GBM patients in the autologous setting. The primary endpoint of the study is overall survival ; secondary endpoints include tolerability, progression-free survival , overall response rate and time to progression • Promising preclinical data in ovarian cancer announced at the American Society of Gene & Cell Therapy Annual Mee..."
05/12/2023 8-K Quarterly results
Docs: "IN8bio Reports First Quarter 2023 Financial Results and Provides Corporate Update • Presented positive INB-100 data showing long-term complete remissions and elevated gamma-delta T cell levels in 100% of evaluable treated leukemia patients; Dose Level 2 selected as the recommended Phase 2 dose for the ongoing expansion with clinical updates expected in late 2023. • Progress across preclinical programs, including data demonstrating that gamma-delta T cells have the ability to target other solid tumors, including ovarian cancer, expanding the scope of their potential application beyond brain tumors, as well as encouraging preclinical data in the new INB-330 CAR-T program targeting acute myeloid leukemia . • Obtained FDA orphan drug designation for INB-400 and INB-410, wh..."
12/06/2022 8-K/A Quarterly results
Docs: "8-K/A",
"IN8bio Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress"
08/12/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/17/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "IN8bio Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
09/10/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy